Zhiqiang Wang

5PUBLICATIONS
46CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 30, 2025
The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA.

Hui-Yan Luo, Wei Wei, Pansong Li

|Sep 04, 2025
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study.

Yi Wang, Yifu He, Zhiqiang Wang

|Aug 05, 2025
Interim C-reactive protein levels predict the prognosis of patients with metastatic colorectal cancer receiving immunotherapy: a retrospective cohort study.

Hai-Yan Fu, Yi-Yang Zhang, Jin-Shan Huang

|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

De-Shen Wang, Chao Ren, Shan-Shan Li

|Aug 05, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Feng Wang, Ming-Ming He, Jian Xiao

Pageof 1

Frequent Collaborators

3 joint publications

Rui-Hua Xu

3 joint publications

Hui-Yan Luo

3 joint publications

Ying Yuan

2 joint publications

Jian Xiao